Search

Cipaglucosidase alfa

in Pompe disease. … ,[L45275] and the EMA fully approved the drug on March 27, 2023.

Maraviroc

It was approved for use by the FDA in August, 2007.

Flucytosine

A fluorinated cytosine analog that is used as an antifungal agent.

Curcumin

Curcumin, also known as diferuloylmethane, is an active component in the golden spice turmeric (Curcuma longa) and in [Curcuma xanthorrhiza oil].

Iodipamide

Iodipamide is a water-soluble radiographic contrast media for cholecystography and intravenous cholangiography.

Kojic acid

Voglibose

Voglibose is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. … It is made in India by Ranbaxy Labs and sold under the trade name Volix.

Acipimox

Acipimox inhibits the production of triglycerides by the liver and the secretion of VLDL, which leads indirectly to a modest reduction in LDL and increase in HDL. … It is used in low doses and may have less marked adverse effects, although it is unclear whether the recommended dose is as effective as are standard doses of nicotinic acid.

Ferrous ascorbate

Voxilaprevir

with an HCV regimen containing sofosbuvir without an NS5A inhibitor [L935]. … Notably, Vosevi is approved for use in patients with genotypes 1-6 who have been previously treated with an NS5A inhibitor, or patients with genotypes 1a or 3 infection and have previously been treated